Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents

BACKGROUND: Studies on temporal changes in noninvasive fibrosis indices and liver stiffness measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting antiviral agents (DAAs) are limited. METHODS: We retrospectively enrolled consecutive patients with CHC who had received...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Gastroenterol
Main Authors: Hsu, Wei-Fan, Lai, Hsueh-Chou, Su, Wen-Pang, Lin, Chia-Hsin, Chuang, Po-Heng, Chen, Sheng-Hung, Chen, Hung-Yao, Wang, Hung-Wei, Huang, Guan-Tarn, Peng, Cheng-Yuan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486982/
https://ncbi.nlm.nih.gov/pubmed/31029101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-019-0973-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki